Who
Gregory Paul Winter
Director
Company insider
Files Form 4 as: Director, Bicycle Therapeutics.
In numbers
- Trades disclosed
- 18
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 28 May 2019
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —9,500 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —9,500 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,500 at $0.00 | filing |
| 3 Jan 2023filed 5 Jan 2023 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,750 at $0.00 | filing |
| 3 Jan 2022filed 5 Jan 2022 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 3 Jan 2022filed 5 Jan 2022 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 4 Jan 2021filed 5 Jan 2021 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,000 at $0.00 | filing |
| 14 Apr 2020filed 16 Apr 2020 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —71,450 at $0.00 | filing |
| 14 Apr 2020filed 16 Apr 2020 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code M | —71,450 | filing |
| 2 Jan 2020filed 6 Jan 2020 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 28 May 2019filed 30 May 2019 | BCYC Bicycle Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —42,870 | filing |
| 28 May 2019filed 30 May 2019 | BCYC Bicycle TherapeuticsBiotechnology | SEC FORM 4 Code C | —42,870 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.